Problem
The FDA faces an incentive to delay the approval of new drugs, whereas pharmaceutical firms face an incentive to accelerate the introduction of new drugs. Explain some market realities that may force pharmaceutical firms to introduce new drugs at a more efficient pace.
The response should include a reference list. Double-space, using Times New Roman 12 pnt font, one-inch margins, and APA style of writing and citations.